Cutaneous Oncology News

Today is Melanoma Monday. The annual observance is intended to raise awareness about causes and symptoms of melanoma, the deadliest form of skin cancer.

The first participant has been dosed in the phase 1 study evaluating Ga-A9-3202 for locally advanced or metastatic melanoma imaging, Alpha-9 Oncology announced in a press release.

Healio has compiled April’s most-read news in dermatology.

It took more than 35 years for tumor-infiltrating lymphocytes, which Steven A. Rosenberg, MD, PhD, and colleagues first reported on in 1988 for the treatment of advanced melanoma, to progress enough to gain FDA approval.

Bin Zheng, PhD, has been appointed director of melanoma research in the department of biomedical sciences at Cedars-Sinai Cancer.

A new study finds that dupilumab is associated with an increased risk for cutaneous T-cell lymphoma in patients taking the drug for atopic dermatitis.

Healio has compiled March’s most-read news in dermatology.

When viewing the solar eclipse on April 8, individuals in the United States should not only protect their eyes, but also their skin.

Following a first primary invasive melanoma diagnosis, older adults and men may experience a second case sooner than other patients, according to a study.

Clinicians treating patients with tumor-infiltrating lymphocytes should closely monitor toxicities associated with interleukin-2 and halt administration of the drug if necessary, according to the first guidelines regarding the therapy.